eFinder

eFinder

WHO approves first malaria treatment for babies

Global Health Achievement

psychologyDetected Techniques

warning
Loaded Language 80% confidence
Using words with strong emotional connotations to influence an audience.

fact_checkFact-Check Results

3 claims extracted and verified against multiple sources including cross-references, web search, and Wikipedia.

check_circle Corroborated 3
check_circle
“The World Health Organization announced on Friday that it had given prequalification approval to a malaria treatment for newborns and infants for the first time.”
CORROBORATED
Multiple web search results report that the WHO prequalified a malaria treatment specifically for newborns and infants. The evidence cites the prequalification of Coartem® (artemether-lumefantrine) Baby by the WHO.
menu_book
wikipedia NEUTRAL — World Health Day is a global health awareness day celebrated every year on 7 April, under the sponsorship of the World Health Organization (WHO), as well as other related organizations. In 1948, the W…
https://en.wikipedia.org/wiki/World_Health_Day
menu_book
wikipedia NEUTRAL — The World Health Organization (WHO) is a specialized agency of the United Nations (UN) which coordinates responses to international public health issues and emergencies. It is headquartered in Geneva,…
https://en.wikipedia.org/wiki/World_Health_Organization
menu_book
wikipedia NEUTRAL — The World Health Organization (WHO) ranked the health systems of its 191 member states in its World Health Report 2000. It provided a framework and measurement approach to examine and compare aspects …
https://en.wikipedia.org/wiki/World_Health_Organization_rank…
+ 3 more evidence sources
check_circle
“Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease.”
CORROBORATED
Multiple independent web search results state that artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest malaria patients/infants.
travel_explore
web search NEUTRAL — The newly prequalified treatment, artemether-lumefantrine, is the first antimalarial formulation designed specifically for the youngest malaria patients.
https://www.who.int/news/item/24-04-2026-who-prequalifies-fi…
travel_explore
web search NEUTRAL — Artemether-lumefantrine is the first antimalarial formulation designed specifically for the youngest victims of the mosquito-borne disease.Experts warn of growing malaria drug resistance. Genital muti…
https://www.standardmedia.co.ke/health/health-science/articl…
travel_explore
web search NEUTRAL — The newly introduced combination of artemether and lumefantrine is the first antimalarial formulation that is safe for babies weighing less than 5 kilograms (2.2 pounds).
https://www.dw.com/en/who-approves-first-malaria-drug-for-ba…
check_circle
“Up to now, infants have been treated with formulations intended for older children – carrying a greater risk of dosage errors, side effects and toxicity.”
CORROBORATED
Multiple web search results confirm that previously, infants were treated with formulations intended for older children, which carried risks of dosing errors, side effects, and toxicity.
travel_explore
web search NEUTRAL — Until now, infants with malaria have been treated with formulations intended for older children, which increase the risk of dosing errors, side effects and toxicity. WHO prequalification will enable p…
https://www.who.int/news/item/24-04-2026-who-prequalifies-fi…
travel_explore
web search NEUTRAL — Until now, infants have been treated with drugs developed for older children, which expose the newborns to risks of dosing errors and toxicity.
https://www.dw.com/en/who-approves-first-malaria-drug-for-ba…
travel_explore
web search NEUTRAL — Up to now, infants have been treated with formulations intended for older children — carrying a greater risk of dosage errors, side effects and toxicity.
https://www.channelstv.com/2026/04/24/who-approves-first-mal…

info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.